What is he best known for?
The fields of study he is best known for:
Stuart J. D. Neil mainly focuses on Tetherin, Virology, Cell biology, Endocytosis and Virus.
His work focuses on many connections between Tetherin and other disciplines, such as Endocytic cycle, that overlap with his field of interest in Molecular biology.
His research related to Viral envelope, Virus Release, Retrovirus, Ebola virus and Viral replication might be considered part of Virology.
His Cell biology research incorporates elements of C-terminus, Interleukin 8, Leukocyte emigration, In vivo and Transcytosis.
The Endocytosis study combines topics in areas such as Endosome and Cell membrane.
He has researched Virus in several fields, including Cell culture and Cohort.
His most cited work include:
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu (1485 citations)
- Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells (645 citations)
- Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin (332 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Tetherin, Virus, Cell biology and Immunology.
His Virology study combines topics in areas such as Epitope, Antibody and Immune system.
His work carried out in the field of Tetherin brings together such families of science as Plasma protein binding, Human Immunodeficiency Virus Proteins, Virus Release, Function and Endocytic cycle.
Stuart J. D. Neil studies Cell biology, focusing on Endosome in particular.
Stuart J. D. Neil has included themes like Endocytosis, Clathrin and Cell membrane in his Endosome study.
In general Immunology study, his work on Chemokine and Tropism often relates to the realm of Population, thereby connecting several areas of interest.
He most often published in these fields:
- Virology (56.84%)
- Tetherin (31.58%)
- Virus (31.58%)
What were the highlights of his more recent work (between 2018-2021)?
- Severe acute respiratory syndrome coronavirus 2 (10.53%)
- Serology (9.47%)
- Virology (56.84%)
In recent papers he was focusing on the following fields of study:
Severe acute respiratory syndrome coronavirus 2, Serology, Virology, Cohort and Cell biology are his primary areas of study.
Stuart J. D. Neil interconnects Internal medicine and Infection control, Intensive care medicine in the investigation of issues within Serology.
The Virology study combines topics in areas such as Epitope and Viral rna.
His Cohort study incorporates themes from Antibody and Disease.
His Cell biology research includes elements of RNA, RNA virus, Interferon and Viral replication.
His study in Viral replication is interdisciplinary in nature, drawing from both Viral envelope, Cleavage and Transmembrane protein.
Between 2018 and 2021, his most popular works were:
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. (279 citations)
- Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection (254 citations)
- Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. (75 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Serology, Cohort, Population, CpG site and RNA.
When carried out as part of a general Serology research project, his work on Seroprevalence is frequently linked to work in Severe acute respiratory syndrome coronavirus 2, therefore connecting diverse disciplines of study.
His biological study spans a wide range of topics, including Disease and Immunology.
His TRIM25 research integrates issues from Effector, Protein domain, Viral replication and Murine leukemia virus.
His Interferon study is focused on Virology in general.
His Cell biology study frequently draws connections to adjacent fields such as Virus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
